the executive committee or chief executive officer to have an authority regarding the determination and alteration of the date, time, and venue of the Extraordinary General Meeting of Shareholders No. 1

interest Total 1. Balance at the beginning 25x0 x x x x x x x (x) x x 2. Accumulation from write off x x x 3. Adjusted balance x x x x x x x (x) x x Alteration between a period 4. Appraisal surplus x x 5

off x x x 3. Adjusted balance x x x x x x x (x) x x Alteration between a period 4. Appraisal surplus x x 5. Revaluation surplus (deficit) in investment x x 6. Retained earning (deficit) arising from

x (x) x x 2. Accumulation from write off x x x 3. Adjusted balance x x x x x x x (x) x x Alteration between a period 4. Appraisal surplus x x 5. Revaluation surplus (deficit) in investment x x 6

Extraordinary General Meeting of Shareholders No. 1/2019 to consider approving the allocation of the newly issued ordinary shares of the Company to accommodate the adjustment of the exercise price and ratio of

December 2024 remains a business day for securities companies and derivatives business operators. This adjustment aligns with the holiday schedule of financial institutions and prevents undue cost burdens on

upon any members of executive committee (its agent), managing director (its agent) regarding the determination, and alteration of the date, time, and venue of the Extraordinary General Meeting of

meeting, and has voting rights, excluded the vote of shareholders who has conflict of interest. Furthermore, there is a resolution passed to confer the power regarding (1) the determination, and alteration

determination, and alteration of the date, time, and venue of the Extraordinary General Meeting No. 1/2019, together with (2) the alteration or addition of the agenda of such meeting, as well as (3) alteration of

has decreased by 6.30% despite total hospital income from general patients increased 8.69% compared with the same period of last year. This is mainly due to the medical-service-fee adjustment caused by